Researchers from Shandong University looked at 26 studies on human subjects and garlic (Allium sativum) consumption.
A meta-analysis on garlic and heart health has linked consumption of the onion relative to lower cholesterol and triglyceride levels.
Researchers from Shandong University looked at 26 studies on human subjects and garlic (Allium sativum) consumption. Compared to placebo, consumption of garlic provided total cholesterol reduction by 0.28 mmol/L and triglyceride reduction by 0.13 mmol/L. Garlic use did not significantly affect LDL or HDL cholesterol compared to placebo.
Garlic supplementation used in the various studies included garlic oil, garlic powder, and aged garlic extract. Subjects who consumed garlic for longer periods or who had higher cholesterol levels at the beginnings of trials tended to see better results.
“Although the size of the effect is modest, garlic therapy should benefit patients with risk of cardiovascular diseases, as garlic may also reduce blood pressure, decrease plasma viscosity, etc.,” wrote the authors of the meta-analysis. “Future studies should be conducted to illustrate the active compounds in garlic responsible for the hypolipidemic effects, to explore the influence of gender on garlic’s effects, and to compare the efficiency between garlic and regular lipid-lowering drugs such as statins and fibrates.”
The meta-analysis included 22 studies on both men and women and four studies on men only. Eight studies were reported as being at least partly funded by industry.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.